Fertility: There are no relevant data available.
Pregnancy: Piracetam should not be used during pregnancy unless clearly necessary, when benefit exceeds the risks and the clinical condition of the pregnant mother requires treatment with piracetam. There are no adequate data from the use of piracetam in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or post-natal development.
Piracetam crosses the placental barrier. Drug levels in the newborn are approximately 70% to 90% of maternal levels.
Lactation: Piracetam should not be used during breastfeeding or breastfeeding should be discontinued while receiving treatment with piracetam. A decision must be made whether to discontinue breastfeeding or to discontinue piracetam therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman.
Piracetam is excreted in human breast milk.